These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 26215483

  • 1. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.
    Hara R, Miyazawa H, Nishimura K, Momoi T, Nozawa T, Kikuchi M, Sakurai N, Kizawa T, Shimamura S, Yasuda S, Hiromura K, Sada KE, Kawaguchi Y, Tamura N, Takei S, Takasaki Y, Atsumi T, Mori M.
    Mod Rheumatol; 2015; 25(6):858-64. PubMed ID: 26215483
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T, Nozawa T, Kikuchi M, Nagahama K, Okudela K, Miyamae T, Imagawa T, Nakamura T, Mori M, Yokota S, Tsutsumi H.
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C, Vollenhoven Rv.
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
    Tselios K, Gladman DD, Su J, Urowitz MB.
    J Rheumatol; 2016 Mar; 43(3):552-8. PubMed ID: 26773121
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
    Weng MY, Weng CT, Liu MF.
    Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879
    [Abstract] [Full Text] [Related]

  • 6. [The efficacy of mycophenolate mofetil for systemic lupus erythematosus].
    Suzuki D, Ogawa N, Sawada J, Kimoto O, Shimoyama K, Hayashi H.
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug; 32(4):263-8. PubMed ID: 19721347
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M.
    Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
    [Abstract] [Full Text] [Related]

  • 8. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K, Ross S, Benz K, Amann K, Dötsch J.
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [Abstract] [Full Text] [Related]

  • 9. Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.
    Abe Y, Tada K, Yamaji K, Tamura N.
    Biomed Res Int; 2021 Dec; 2021():8630596. PubMed ID: 33564682
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus: A Randomized Clinical Trial.
    You Y, Zhou Z, Wang F, Li J, Liu H, Cheng X, Su Y, Chen X, Zheng H, Sun Y, Shi H, Hu Q, Xu J, Teng J, Yang C, Ye J.
    JAMA Netw Open; 2024 Sep 03; 7(9):e2432131. PubMed ID: 39283640
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.
    Nannini C, Crowson CS, Matteson EL, Moder KG.
    Lupus; 2009 Apr 03; 18(5):394-9. PubMed ID: 19318390
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
    Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G.
    Immunol Res; 2014 Dec 03; 60(2-3):270-6. PubMed ID: 25468307
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN, Karim Y, Cuadrado MJ.
    Lupus; 2005 Dec 03; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
    Kawazoe M, Kaneko K, Yamada Z, Masuoka S, Mizutani S, Yamada S, Shikano K, Sato H, Kaburaki M, Muraoka S, Kawai S, Nanki T.
    Clin Rheumatol; 2019 Jun 03; 38(6):1571-1578. PubMed ID: 30778862
    [Abstract] [Full Text] [Related]

  • 15. Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan.
    Yasuda S, Atsumi T, Shimamura S, Ono K, Hiromura K, Sada K, Mori M, Takei S, Kawaguchi Y, Tamura N, Takasaki Y.
    Mod Rheumatol; 2015 Jun 03; 25(6):854-7. PubMed ID: 25800636
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.
    Mino Y, Naito T, Shimoyama K, Ogawa N, Kawakami J.
    Ann Clin Biochem; 2017 Jul 03; 54(4):490-494. PubMed ID: 27538768
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A.
    J Rheumatol; 2001 Sep 03; 28(9):2103-8. PubMed ID: 11550982
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
    Mak A, Mok CC.
    Lupus; 2005 Sep 03; 14(10):856-8. PubMed ID: 16302683
    [Abstract] [Full Text] [Related]

  • 19. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.
    Szyper-Kravitz M, Sheinberg P, Sidi Y, Schiffenbauer Y, Trubniykov E, Shoenfeld Y.
    Int Arch Allergy Immunol; 2005 Dec 03; 138(4):334-6. PubMed ID: 16224194
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M, Jancova E, Rysava R, Merta M, Tesar V.
    Arch Med Res; 2008 Jan 03; 39(1):115-9. PubMed ID: 18068004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.